Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-Operative Docetaxel + Laparoscopic Radical Prostatectomy in Prostate Cancer
NCT00127088Phase 2Suspended
- Sponsor
- Gustave Roussy
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in prostate cancer (PCa), sponsored by Gustave Roussy. Primary endpoint: Complete prostate specific antigen (PSA) response rate. Started Oct 2004; status: suspended.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00127088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127088.